Intuity Medical and embecta Launch Commercial Collaboration, Expanding Access to Self-Management Innovations for People With Diabetes
07 nov. 2022 06h50 HE
|
Embecta Corp.
FREMONT, Calif. and PARSIPPANY, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Intuity Medical, Inc. and Embecta Corp. (“embecta”) (NASDAQ: EMBC) today announced they have signed a co-promotional agreement...
embecta to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results
03 nov. 2022 17h00 HE
|
Embecta Corp.
PARSIPPANY, N.J., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, will host a conference call to...
embecta to Recognize National Diabetes Awareness Month by Ringing Nasdaq Opening Bell
01 nov. 2022 06h50 HE
|
Embecta Corp.
PARSIPPANY, N.J., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today announced it will ring the...
embecta to Participate in Upcoming Investor Conferences in September
18 août 2022 17h00 HE
|
Embecta Corp.
PARSIPPANY, N.J., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will participate in the following upcoming investor conferences: The 2022...
Embecta Corp. Reports Third Quarter Fiscal 2022 Financial Results
15 août 2022 06h30 HE
|
Embecta Corp.
PARSIPPANY, N.J., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world following its April 1, 2022, spin off...
embecta Announces Inaugural Quarterly Cash Dividend
15 août 2022 06h00 HE
|
Embecta Corp.
PARSIPPANY, N.J., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (NASDAQ: EMBC), one of the largest pure-play diabetes care companies, announced today that its Board of Directors...
embecta Announces Earnings Conference Call Information for the Third Quarter of Fiscal Year 2022
05 juil. 2022 17h00 HE
|
Embecta Corp.
PARSIPPANY, N.J., July 05, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (NASDAQ: EMBC), one of the largest pure-play diabetes care companies in the world following its April 1, 2022, spin off...
Embecta Corp. Reports Second Quarter and First Six Months of Fiscal Year 2022 Financial Results and Provides Financial Guidance for the Last Six Months of Fiscal Year 2022
13 mai 2022 06h30 HE
|
Embecta Corp.
PARSIPPANY, N.J., May 13, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world following its April 1, 2022, spin off...
embecta to Participate in Upcoming Investor Conferences in May
09 mai 2022 16h05 HE
|
Embecta Corp.
PARSIPPANY, N.J., May 09, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will participate in the following upcoming investor conferences: The 2022...
embecta Announces Second Quarter 2022 Earnings Conference Call Information
19 avr. 2022 06h50 HE
|
Embecta Corp.
FRANKLIN LAKES, N.J., April 19, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (NASDAQ: EMBC) today announced that it will report its financial results for the second quarter of fiscal year 2022...